Understanding how B-cell lymphoma evades the immune system
A Novel Mechanism of Immune Escape by B-cell Lymphoma
This study is looking at how certain blood cancers called B-cell lymphomas hide from the immune system and how a molecule named FCRLA helps them do that, with the goal of finding new ways to boost the immune response and improve treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ralph H Johnson VA Medical Center NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-10951499 on NIH RePORTER |
What this research studies
This research investigates how B-cell lymphomas develop mechanisms to escape detection by the immune system, particularly focusing on the role of a molecule called FCRLA. The study aims to understand how this molecule impairs the ability of immune cells to recognize and attack the tumor. By blocking the effects of FCRLA, the researchers hope to enhance the immune response against B-cell lymphomas, potentially leading to more effective treatments. Patients may be involved in trials that explore new therapies targeting this immune evasion mechanism.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with B-cell lymphoma who may benefit from new immunotherapy approaches.
Not a fit: Patients with other types of cancers or those without B-cell lymphoma may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients with B-cell lymphoma by enhancing their immune response against the cancer.
How similar studies have performed: Other research has shown promise in targeting immune evasion mechanisms in cancers, suggesting that this approach could be effective.
Where this research is happening
Charleston, United States
- Ralph H Johnson VA Medical Center — Charleston, United States (Active)
Researchers
- Principal investigator: Haque, Azizul — Ralph H Johnson VA Medical Center
- Study coordinator: Haque, Azizul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.